Vaccine (Recombinant protein vaccine) · Immune activation, directed at Neisseria meningitidis serogroups A, C, W, Y capsular polysaccharides · developed by Sanofi Pasteur, a Sanofi Company
MenACYW conjugate vaccine is a meningococcal vaccine given by intramuscular injection, intended to induce immunity against Neisseria meningitidis serogroups A, C, W and Y. It is being studied for meningococcal infection in healthy volunteers.
Summary written with AI from the sources listed at the end of this page.
Healthy VolunteersMeningococcal Infection
Updated Nov 1, 2026. Something wrong or missing? Report it on the SNY page.
See SNY's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
SNY catalysts and pipeline →